Efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg for the management of overweight or obesity in Asian populations: A systematic review, meta-analysis and meta …
Publication Name : Diabetes, Obesity and Metabolism 27 (11), 6632-6643, 2025
Citation :
Date : 2025